TCT 2011 | San Francisco, CA | November 10, 2011 Two-Year Outcomes of Transcatheter Aortic Valve Replacement (TAVR) in Inoperable Patients With Severe.
TCT 2012 | Miami, FL | October 24, 2012 Three-Year Outcomes of Transcatheter Aortic Valve Replacement (TAVR) inInoperable Patients With Severe Aortic Stenosis:
Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial
Matthew R. Reynolds, M.D., M.Sc. On Behalf of the PARTNER Investigators Lifetime Cost Effectiveness of Transcatheter Aortic Valve Replacement Compared.
